Company news
Resverlogix Corp. news in 2010
Resverlogix Corp.'s news releases, calls and decks from 2010, newest first.
Resverlogix Appoints Dr. Eldon R. Smith to Board of Directors
December 13, 2010
Successful ASSERT Trial Results in Resverlogix Filing New RVX-208 Patent
November 29, 2010
Resverlogix Notice of Conference Call & Webcast to Provide a Market Update
November 25, 2010
Resverlogix Presents ASSERT Human Clinical Trial Data at the American Heart Association Late Breaker Session
November 17, 2010
Resverlogix Notice of Conference Call & Webcast to Discuss ASSERT Clinical Trial Data
November 15, 2010
Resverlogix Appoints Kenneth J. Zuerblis to Board of Directors
September 30, 2010
Resverlogix's Phase 2 ASSURE Trial Amended
September 10, 2010
Resverlogix Surpasses $1 Billion Trading Milestone
August 23, 2010
Resverlogix Scientific Data Presented at EAS Congress
June 22, 2010
Resverlogix Announces CDN $10 Million Equity Offering
June 16, 2010
Resverlogix Settles Draw Down on Standby Equity Distribution Agreement
June 11, 2010
Resverlogix Publishes Data Confirming RVX-208's Impact on Reverse Cholesterol Transport
June 8, 2010
Resverlogix Confirms CDN $9.2 Million Offering
June 3, 2010
Resverlogix Announces Financing
June 2, 2010
Resverlogix Announces Intention to Draw Down $1 Million on Standby Equity Distribution Agreement
May 26, 2010
Resverlogix Completes Dosing for ASSERT Trial
May 12, 2010
Resverlogix Notice of Conference Call & Webcast for Year End Update
May 10, 2010
Resverlogix Scientific Data Presented at ATVB Conference
April 9, 2010
Resverlogix Activates Standby Equity Distribution Agreement
March 29, 2010
GuestLogix Inc. and Redknee Solutions Inc. Under Current Evaluation
March 9, 2010
Resverlogix Market Update
March 5, 2010
Resverlogix Activates First Site for ASSURE 1 Clinical Trial
February 25, 2010
Resverlogix Completes Patient Recruitment for ASSERT Trial
February 8, 2010
Arthur J. Higgins, CEO of Bayer HealthCare, Appointed to Resverlogix Board of Directors
February 1, 2010
Resverlogix Announces the Closing of an Additional $8 Million Financing
January 28, 2010
Resverlogix Presenting at Biotech Showcase
January 11, 2010
Resverlogix Confirms the Completion of Full Debenture Repurchase
January 7, 2010